Follow
D R Mani
D R Mani
Broad Institute of MIT and Harvard
Verified email at broadinstitute.org
Title
Cited by
Cited by
Year
Proteogenomics connects somatic mutations to signalling in breast cancer
P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ...
Nature 534 (7605), 55-62, 2016
15262016
An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data
LN Mueller, MY Brusniak, DR Mani, R Aebersold
Journal of proteome research 7 (01), 51-61, 2008
11652008
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification
CL Nutt, DR Mani, RA Betensky, P Tamayo, JG Cairncross, C Ladd, ...
Cancer research 63 (7), 1602-1607, 2003
11602003
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
TA Addona, SE Abbatiello, B Schilling, SJ Skates, DR Mani, DM Bunk, ...
Nature biotechnology 27 (7), 633-641, 2009
11362009
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
8832016
Lenalidomide induces ubiquitination and degradation of CK1α in del (5q) MDS
J Krönke, EC Fink, PW Hollenbach, KJ MacBeth, SN Hurst, ND Udeshi, ...
Nature 523 (7559), 183-188, 2015
7902015
Integrated proteomic analysis of post-translational modifications by serial enrichment
P Mertins, JW Qiao, J Patel, ND Udeshi, KR Clauser, DR Mani, ...
Nature methods 10 (7), 634-637, 2013
6482013
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ...
Cell 177 (4), 1035-1049. e19, 2019
5562019
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ...
Molecular & Cellular Proteomics 13 (3), 907-917, 2014
5522014
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
4432020
Integrated proteogenomic characterization of clear cell renal cell carcinoma
DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ...
Cell 179 (4), 964-983. e31, 2019
4362019
Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels
P Mertins, F Yang, T Liu, DR Mani, VA Petyuk, MA Gillette, KR Clauser, ...
Molecular & cellular proteomics 13 (7), 1690-1704, 2014
3892014
Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution
H Keshishian, T Addona, M Burgess, DR Mani, X Shi, E Kuhn, ...
Molecular & cellular proteomics 8 (10), 2339-2349, 2009
3892009
Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry
P Mertins, LC Tang, K Krug, DJ Clark, MA Gritsenko, L Chen, KR Clauser, ...
Nature protocols 13 (7), 1632-1661, 2018
3772018
Proteogenomic and metabolomic characterization of human glioblastoma
LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ...
Cancer cell 39 (4), 509-528. e20, 2021
3762021
Identifying the proteins to which small-molecule probes and drugs bind in cells
SE Ong, M Schenone, AA Margolin, X Li, K Do, MK Doud, DR Mani, ...
Proceedings of the National Academy of Sciences 106 (12), 4617-4622, 2009
3722009
Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry
E Kuhn, T Addona, H Keshishian, M Burgess, DR Mani, RT Lee, ...
Clinical chemistry 55 (6), 1108-1117, 2009
3462009
Prediction of high-responding peptides for targeted protein assays by mass spectrometry
VA Fusaro, DR Mani, JP Mesirov, SA Carr
Nature biotechnology 27 (2), 190-198, 2009
3452009
Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis
RK Khajuria, M Munschauer, JC Ulirsch, C Fiorini, LS Ludwig, ...
Cell 173 (1), 90-103. e19, 2018
3422018
Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000 s of ubiquitination sites in single proteomics experiments
ND Udeshi, T Svinkina, P Mertins, E Kuhn, DR Mani, JW Qiao, SA Carr
Molecular & Cellular Proteomics 12 (3), 825-831, 2013
3412013
The system can't perform the operation now. Try again later.
Articles 1–20